[Federal Register Volume 59, Number 125 (Thursday, June 30, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-15831]


[[Page Unknown]]

[Federal Register: June 30, 1994]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration
[Docket No. 94G-0082]

 

Nabisco, Inc; Filing of Petition for Affirmation of GRAS Status

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that 
Nabisco, Inc., has filed a petition (GRASP 4G0404) proposing to affirm 
that short- and long-chain fatty acid triacylglycerols are generally 
recognized as safe (GRAS) as direct human food ingredients. Nabisco, 
Inc., has proposed the common or usual name SALATRIM for this class of 
substances. SALATRIM is an acronym formed from the term ``short- and 
long-chain acid triacylglycerol molecules.''

DATES: Written comments by August 29, 1994.

ADDRESSES: Submit written comments to the Dockets Management Branch 
(HFA-305), Food and Drug Administration, rm. 1-23, 12420 Parklawn Dr., 
Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT: F. Owen Fields, Center for Food Safety 
and Applied Nutrition (HFS-207), Food and Drug Administration, 200 C 
St. SW., Washington, DC 20204, 202-254-9528.

SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic 
Act (secs. 201(s) and 409 (21 U.S.C. 321(s) and 348)) and the 
regulations for affirmation of GRAS status in Sec. 170.35 (21 CFR 
170.35), notice is given that Nabisco, Inc., 200 DeForest Ave., East 
Hanover, NJ 07936, has filed a petition (GRASP 4G0404) proposing that 
short- and long-chain fatty acid triacylglycerols be affirmed as GRAS 
for use as direct human food ingredients. Nabisco, Inc., has proposed 
the common or usual name SALATRIM for this class of substances. 
SALATRIM is an acronym formed from the term ``short-and long-chain acid 
triacylglycerol molecules.''
    The petition has been placed on display at the Dockets Management 
Branch (address above).
    Any petition that meets the requirements outlined in Sec. 170.30 
(21 CFR 170.30) and Sec. 170.35 is filed by the agency. There is no 
prefiling review of the adequacy of data to support a GRAS conclusion. 
Thus, the filing of a petition for GRAS affirmation should not be 
interpreted as a preliminary indication of suitability for GRAS 
affirmation.
    The potential environmental impact of this action is being 
reviewed. If the agency finds that an environmental impact statement is 
not required and this petition results in a regulation, the notice of 
availability of the agency's finding of no significant impact and the 
evidence supporting that finding will be published with the regulation 
in the Federal Register in accordance with 21 CFR 25.40(c).
    Interested persons may, on or before August 29, 1994, review the 
petition and/or file comments with the Dockets Management Branch 
(address above). Two copies of any comments should be filed and should 
be identified with the docket number found in brackets in the heading 
of this document. Comments should include any available information 
that would be helpful in determining whether the substance is, or is 
not, GRAS for the proposed use. In addition, consistent with the 
regulations promulgated under the National Environmental Policy Act (40 
CFR 1501.4(b)), the agency encourages public participation by review of 
and comment on the environmental assessment submitted with the petition 
that is the subject of this notice. A copy of the petition (including 
the environmental assessment) and received comments may be seen in the 
Dockets Management Branch between 9 a.m. and 4 p.m., Monday through 
Friday.

    Dated: June 17, 1994.
Fred R. Shank,
Director, Center for Food Safety and Applied Nutrition.
[FR Doc. 94-15831 Filed 6-29-94; 8:45 am]
BILLING CODE 4160-01-F